The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Dale, J. A., & Mosher, H. S. (1973) · Journal of the American Chemical Society · doi:10.1021/ja00783a034 · Cited by 2,593
Encyclopedia of nuclear magnetic resonance
(2003) · TrAC Trends in Analytical Chemistry · doi:10.1016/s0165-9936(03)00914-2 · Cited by 1,656
Separation of enantiomers: needs, challenges, perspectives
Maier, N. M., Franco, P., & Lindner, W. (2001) · Journal of Chromatography A · doi:10.1016/s0021-9673(00)00532-x · Cited by 1,014
The Assignment of Absolute Configuration by NMR
Seco, J. M., Quiñoá, E., & Riguera, R. (2004) · Chemical Reviews · doi:10.1021/cr000665j · Cited by 983
Hoye, T. R., Jeffrey, C. S., & Shao, F. (2007) · Nature Protocols · doi:10.1038/nprot.2007.354 · Cited by 776
The use of X‐ray crystallography to determine absolute configuration
Flack, H. D., & Bernardinelli, G. (2008) · Chirality · doi:10.1002/chir.20473 · Cited by 707
Putting chirality to work: the strategy of chiral switches
Agranat, I., Caner, H., & Caldwell, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd915 · Cited by 637
Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology
Ari�ns, E. J. (1984) · European Journal of Clinical Pharmacology · doi:10.1007/bf00541922 · Cited by 609
FDA'S policy statement for the development of new stereoisomeric drugs
(1992) · Chirality · doi:10.1002/chir.530040513 · Cited by 581
Sullivan, G. R., Dale, J. A., & Mosher, H. S. (1973) · The Journal of Organic Chemistry · doi:10.1021/jo00952a006 · Cited by 505
Yashima, E. (2001) · Journal of Chromatography A · doi:10.1016/s0021-9673(00)00501-x · Cited by 478
A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole
Olbe, L., Carlsson, E., & Lindberg, P. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1010 · Cited by 418
Trends in the development of chiral drugs
Caner, H., Groner, E., Levy, L., & Agranat, I. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02904-0 · Cited by 399
Hutt, A. J., & Caldwell, J. (1983) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1983.tb02874.x · Cited by 394
Stephens, P. J., Devlin, F. J., & Pan, J. (2008) · Chirality · doi:10.1002/chir.20477 · Cited by 366
Molecular obesity, potency and other addictions in drug discovery
Hann, M. M. (2011) · MedChemComm · doi:10.1039/c1md00017a · Cited by 363
He, Y., Wang, B., Dukor, R. K., & Nafié, L. A. (2011) · Applied Spectroscopy · doi:10.1366/11-06321 · Cited by 341
Supercritical fluid chromatography for the 21st century
Taylor, L. T. (2009) · The Journal of Supercritical Fluids · doi:10.1016/j.supflu.2008.09.012 · Cited by 298
Seco, J. M., Quiñoá, E., & Riguera, R. (2012) · Chemical Reviews · doi:10.1021/cr2003344 · Cited by 294
(2006) · Methods and Principles in Medicinal Chemistry · doi:10.1002/3527609431 · Cited by 278
Leeson, P. (2012) · Nature · doi:10.1038/481455a · Cited by 266
Chiral separation by chromatographic and electromigration techniques. A Review
Gübitz, G., & Schmid, M. G. (2001) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.279 · Cited by 242
Fundamental challenges and opportunities for preparative supercritical fluid chromatography
Guiochon, G., & Tarafder, A. (2011) · Journal of Chromatography A · doi:10.1016/j.chroma.2010.12.047 · Cited by 222
Impurities in New Drug Products
(2009) · Handbook of Pharmaceutical Manufacturing Formulations · doi:10.3109/9781420081275-18 · Cited by 205
Fluoroquinolone antibacterials: a review on chemistry, microbiology and therapeutic prospects.
Sharma, P. C., Jain, A., & Jain, S. K. (2010) · PubMed · Cited by 196
Supercritical fluid chromatography for the enantioseparation of pharmaceuticals
De Klerck, K., Mangelings, D., & Vander Heyden, Y. (2012) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2012.01.021 · Cited by 195
Enantioselective chromatography in drug discovery
Zhang, Y., Wu, D.-R., Wang-Iverson, D. B., & Tymiak, A. A. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03407-0 · Cited by 188
History of supercritical fluid chromatography: Instrumental development
Saito, M. (2013) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2012.12.008 · Cited by 188
Metamorphosis of supercritical fluid chromatography to SFC: An Overview
Tarafder, A. (2016) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2016.01.002 · Cited by 154
Intellectual property and chirality of drugs
Agranat, I., & Caner, H. (1999) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01363-x · Cited by 131
Bringmann, G., Gulder, T. A. M., Reichert, M., & Gulder, T. (2008) · Chirality · doi:10.1002/chir.20557 · Cited by 125
Enantioselective Separations with Supercritical Fluids - Review
West, C. (2013) · Current Analytical Chemistry · doi:10.2174/1573411011410010009 · Cited by 114
Roussel, C., Río, A. D., Pierrot‐Sanders, J., Piras, P., & Vanthuyne, N. (2004) · Journal of Chromatography A · doi:10.1016/j.chroma.2004.01.065 · Cited by 112
Determination of absolute configurations by X‐ray crystallography and 1H NMR anisotropy
Harada, N. (2007) · Chirality · doi:10.1002/chir.20478 · Cited by 106
McConnell, O. J., Bach, A., Balibar, C. J., Byrne, N., Cai, Y., Carter, G., Chlenov, M. A., Di, L., Fan, K. Y., Goljer, I., et al. (2007) · Chirality · doi:10.1002/chir.20399 · Cited by 106
From Racemates to Single Enantiomers – Chiral Synthetic Drugs over the last 20 Years
Murakami, H. (2006) · Topics in current chemistry · doi:10.1007/128_2006_072 · Cited by 98
Mullard, A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.15 · Cited by 94
Stereoselective Disposition of Proton??Pump Inhibitors
Andersson, T., & Weidolf, L. O. G. (2008) · Clinical Drug Investigation · doi:10.2165/00044011-200828050-00001 · Cited by 92
Preparative chiral chromatographic resolution of enantiomers in drug discovery.
Andersson, S., & Allenmark, S. (2002) · Journal of Biochemical and Biophysical Methods · doi:10.1016/s0165-022x(02)00126-4 · Cited by 90
Matthijs, N., Maftouh, M., & Heyden, Y. V. (2006) · Journal of Chromatography A · doi:10.1016/j.chroma.2006.01.106 · Cited by 85
The predicated demise of racemic new molecular entities is an exaggeration
Agranat, I., Wainschtein, S. R., & Zusman, E. Z. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3657-c1 · Cited by 85
The strategy of enantiomer patents of drugs
Agranat, I., & Wainschtein, S. R. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.01.007 · Cited by 61
Preparative Scale Resolution of Enantiomers Enables Accelerated Drug Discovery and Development
Leek, H., & Andersson, S. (2017) · Molecules · doi:10.3390/molecules22010158 · Cited by 61
Chiral NMR Solvating Additives for Differentiation of Enantiomers
Uccello‐Barretta, G., & Balzano, F. (2013) · Topics in current chemistry · doi:10.1007/128_2013_445 · Cited by 58
Klerck, K. D., Parewyck, G., Mangelings, D., & Heyden, Y. V. (2012) · Journal of Chromatography A · doi:10.1016/j.chroma.2012.07.090 · Cited by 53
Mansfield, P. R., Henry, D. A., & Tonkin, A. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443050-00002 · Cited by 53
Branch, S. K., & Agranat, I. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm402001w · Cited by 50
Meanwell, N. A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00915 · Cited by 40
Pharmacodynamics, pharmacokinetics and toxicity of ibuprofen enantiomers
Mayer, J. M., & Testa, B. (1997) · Drugs of the Future · doi:10.1358/dof.1997.022.12.711853 · Cited by 39
D’Acquarica, I. (2007) · CRC Press eBooks · doi:10.1201/9781420060263-4 · Cited by 35
Self-citationSrinivasu, G., Kumar, K. N., Thirupathi, C., Narayana, C. L., & Murthy, C. P. (2016) · Chromatographia · doi:10.1007/s10337-016-3157-2 · Cited by 29
Byrne, N. M., Hayes-Larson, E., Liao, W.-W., & Kraml, C. M. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.06.057 · Cited by 27
Cited by
Chiral covalent organic frameworks: design, synthesis and property
Han, X., Yuan, C., Hou, B., Liu, L., Li, H., Liu, Y., & Cui, Y. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00009d · Cited by 478
Peluso, P., & Chankvetadze, B. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00846 · Cited by 371
Chiral AIEgens – Chiral recognition, CPL materials and other chiral applications
Hu, M., Feng, H.-T., Yuan, Y.-X., Zheng, Y.-S., & Tang, B. Z. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213329 · Cited by 318
Chirality of New Drug Approvals (2013–2022): Trends and Perspectives
McVicker, R. U., & O’Boyle, N. M. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02239 · Cited by 255
Metadata
- Authors
- Calcaterra, A., & D’Acquarica, I.
- Venue
- Journal of Pharmaceutical and Biomedical Analysis
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 147
- Pages
- 323-340
- ISSN
- 0731-7085 (ISSN-L)
- OpenAlex
- W2734647920
- Cited by
- 481
- References
- 54
- FWCI
- 16.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.